Últimas Noticias (En Inglés)
Dr. M. Parvez Alam from the Drug Discovery lab at UCLA’s Mary S. Easton Center for Alzheimer's Disease Research displays his award received at the recent Flow Chemistry Congress 2015 held in San Diego, September 15-16 for best presentation: "High Yield SNAr Substitution Reaction of Heteroaryl Chlorides in a MicroFluidic Reactor."Article: "Green Chemistry" approach wins award at Flow Chemistry Congress.
Alzheimer's Disease Study Grabs Attention UCLA Newsroom, Dot.Med, MedicalXpress, and Examiner.com Sept. 16 and Drug Discovery & Development, NewsMax, Bioscience Technology, Financial Express, Laboratory Equipment, Medical News Today, Psychiatry Advisor, Health Canal, Siasat Daily, Web India, Top News, Science Daily, Asian News International, Business Standard, Big News Network, and New Kerala Sept. 17 reported on a study by Dr. Dale Bredesen that found that Alzheimer’s disease has three distinct subtypes. Bredesen is a UCLA visiting professor of neurology.
Newswise, Science Daily, Drug Discovery and Development, Examiner.com, MedicalXpress, News-Medical.net and NewsMax reported July 29 on a study by Dr. Varghese John that found a naturally occurring protein inhibits an enzyme linked to the onset of Alzheimer’s. John is an Associate Adjunct Professor of Neurology and Principle Investigator of the Drug Discovery Lab in the Mary S. Easton Center for Alzheimer's Disease Research at UCLA.